These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 25705695)
1. Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study. Adelman RA; Parnes AJ; Bopp S; Saad Othman I; Ducournau D Biomed Res Int; 2015; 2015():870987. PubMed ID: 25705695 [TBL] [Abstract][Full Text] [Related]
2. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239 [TBL] [Abstract][Full Text] [Related]
3. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA; BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664 [TBL] [Abstract][Full Text] [Related]
4. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion. Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480 [TBL] [Abstract][Full Text] [Related]
5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
6. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion. Sohn HJ; Han DH; Lee DY; Nam DH Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803 [TBL] [Abstract][Full Text] [Related]
7. Reading speed improvements in retinal vein occlusion after ranibizumab treatment. Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977 [TBL] [Abstract][Full Text] [Related]
9. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652 [TBL] [Abstract][Full Text] [Related]
11. Surgical macular decompression for macular edema in retinal vein occlusion. Mandelcorn MS; Mandelcorn E; Guan K; Adatia FA Can J Ophthalmol; 2007 Feb; 42(1):116-22. PubMed ID: 17361252 [TBL] [Abstract][Full Text] [Related]
12. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections. Alshareef RA; Garg SJ; Hsu J; Vander J; Park C; Spirn MJ J Ocul Pharmacol Ther; 2014 Aug; 30(6):512-6. PubMed ID: 24828198 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes. Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: eighteen-month results of a prospective trial. Zhang H; Liu ZL; Sun P; Gu F J Ocul Pharmacol Ther; 2011 Dec; 27(6):615-21. PubMed ID: 21823986 [TBL] [Abstract][Full Text] [Related]
16. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066 [TBL] [Abstract][Full Text] [Related]
17. Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab. Eadie JA; Ip MS; Kulkarni AD Retina; 2014 Dec; 34(12):2439-43. PubMed ID: 24999721 [TBL] [Abstract][Full Text] [Related]
18. Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion. Raszewska-Steglinska M; Gozdek P; Cisiecki S; Michalewska Z; Michalewski J; Nawrocki J Eur J Ophthalmol; 2009; 19(6):1055-62. PubMed ID: 19882567 [TBL] [Abstract][Full Text] [Related]
19. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753 [TBL] [Abstract][Full Text] [Related]
20. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months. Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ Retina; 2010; 30(7):1002-11. PubMed ID: 20616679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]